<unk>  is a mitotic inhibitor that is FDA approved for the treatment of metastatic breast cancer, non-small cell lung cancer and adenocarcinoma of the pancreas. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include alopecia, diarrhea, inflammatory disease of mucous membrane, nausea and vomiting, any grade of anemia, leukopenia, any grade of neutropenia, any grade of thrombocytopenia, any grade of hypersensitivity reaction, arthralgia, myalgia and peripheral neuropathy.
Paclitaxel
Zorubicin
Ifosfamide
Doxorubicin hydrochloride
Stibine
Vincristine sulfate
Estramustine
Semustine